| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Viewpoint |
1 From the Department of Radiology, University of Virginia Health System, 1215 Lee St, Charlottesville, VA 22908 (D.J.S., G.D.H.), and Department of Radiology, Dotter Interventional Institute, Oregon Health Sciences University, Portland (J.A.K.). Received April 6, 2001; revision requested May 18; revision received June 28; accepted July 16. Address correspondence to D.J.S. (e-mail: djs4m@virginia.edu).
Gadolinium has physical properties that are well suited for radiographic imaging. Digital subtraction angiography with a gadolinium chelate as contrast medium can provide images of suitable quality for diagnosis and intervention. The overall safety profile of gadolinium-based contrast media is excellent. In particular, these contrast media are well tolerated in patients with renal insufficiency when administered intraarterially in doses of less than 0.3–0.4 mmol per kilogram body weight, with a decreased incidence of contrast medium–induced nephropathy, as compared with similar volumes of iodinated contrast material. The currently available formulations of gadolinium chelates can be injected safely into every arterial and venous structure. However, substantial data are lacking on the intraarterial use of gadolinium in patients with renal insufficiency, particularly at doses that exceed those routinely used in magnetic resonance angiography. Gadolinium chelates in appropriate volumes are useful alternative contrast media in selected high-risk patients undergoing angiographic studies.
© RSNA, 2002
Index terms: Angiography, contrast media, 9*.12112 • Contrast media, complications • Contrast media, effects • Contrast media, toxicity • Gadolinium • Iodine and iodine compounds • Uremia
Related Articles
Radiology 2002 223: 311-318.
Radiology 2002 223: 326-327.
Radiology 2002 223: 328-329.
This article has been cited by other articles:
|
|
 |
|
  S. C. Josephs, H. A. Rowley, G. D. Rubin, and for Writing Group 3 Atherosclerotic Peripheral Vascular Disease Symposium II: Vascular Magnetic Resonance and Computed Tomographic Imaging Circulation, December 16, 2008; 118(25): 2837 - 2844. [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. Weinreb Which Study When? Is Gadolinium-enhanced MR Imaging Safer than Iodine-enhanced CT? Radiology, October 1, 2008; 249(1): 3 - 8. [Full Text] [PDF]
|
|
|
|
 |
|
 P. M. Colletti Nephrogenic Systemic Fibrosis and Gadolinium: A Perfect Storm Am. J. Roentgenol., October 1, 2008; 191(4): 1150 - 1153. [Full Text] [PDF]
|
|
|
|
|
|
M. C. Heinrich, M. K. Kuhlmann, S. Kohlbacher, M. Scheer, A. Grgic, M. B. Heckmann, and M. Uder Cytotoxicity of Iodinated and Gadolinium-based Contrast Agents in Renal Tubular Cells at Angiographic Concentrations: In Vitro Study Radiology, December 19, 2006; (2006) 2422060245. [Abstract] [Full Text]
|
|
|
|
|
|
N. Zorger, M. Volk, O. W. Hamer, M. Lenhart, J. Seitz, B. Butz, and C. Paetzel Intraarterial Gadolinium-Enhanced MR Angiography in Humans for the Detection of Infrainguinal Arterial Stenoses Before and After Percutaneous Angioplasty Am. J. Roentgenol., October 1, 2005; 185(4): 867 - 872. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A.-C. Schulte, G. Bongartz, R. Huegli, M. Aschwanden, K. A. Jaeger, W. Ostheim-Dzerowycz, A. L. Jacob, and D. Bilecen Intraarterial Versus IV Gadolinium Injections for MR Angiography: Quantitative and Qualitative Assessment of the Infrainguinal Arteries Am. J. Roentgenol., September 1, 2005; 185(3): 735 - 740. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. K. Raman, P. V. Karmarkar, M. A. Guttman, A. J. Dick, D. C. Peters, C. Ozturk, B. S.S. Pessanha, R. B. Thompson, A. N. Raval, R. DeSilva, et al. Real-Time Magnetic Resonance-Guided Endovascular Repair of Experimental Abdominal Aortic Aneurysm in Swine J. Am. Coll. Cardiol., June 21, 2005; 45(12): 2069 - 2077. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Remy-Jardin, P. Dequiedt, O. Ertzbischoff, I. Tillie-Leblond, J. Bruzzi, A. Duhamel, and J. Remy Safety and Effectiveness of Gadolinium-enhanced Multi-Detector Row Spiral CT Angiography of the Chest: Preliminary Results in 37 Patients with Contraindications to Iodinated Contrast Agents Radiology, June 1, 2005; 235(3): 819 - 826. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. W. Henson, R. G. Nogueira, D. J. Covarrubias, R. G. Gonzalez, and M. H. Lev Gadolinium-Enhanced CT Angiography of the Circle of Willis and Neck AJNR Am. J. Neuroradiol., June 1, 2004; 25(6): 969 - 972. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. W. Olin, J. A. Kaufman, D. A. Bluemke, R. O. Bonow, M. D. Gerhard, M. R. Jaff, G. D. Rubin, and W. Hall Atherosclerotic Vascular Disease Conference: Writing Group IV: Imaging Circulation, June 1, 2004; 109(21): 2626 - 2633. [Full Text] [PDF]
|
|
|
|
|
|
L. Berlin Should Whole-Body CT Screening Be Performed with Contrast Media? Am. J. Roentgenol., February 1, 2003; 180(2): 323 - 325. [Full Text] [PDF]
|
|
|
|
|
|
U. Nyman, B. Elmstahl, P. Leander, M. Nilsson, K. Golman, and T. Almen Commentary on the Viewpoint of Spinosa et al Radiology, May 1, 2002; 223(2): 326 - 327. [Full Text] [PDF]
|
|
|
|
|
|
D. J. Spinosa, J. A. Kaufmann, and G. D. Hartwell Commentary on the Viewpoint of Nyman et al Radiology, May 1, 2002; 223(2): 328 - 329. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| RADIOLOGY | RADIOGRAPHICS | RSNA JOURNALS ONLINE |
